Advanced search
1 file | 103.80 KB Add to list

Canine lymphoma: a retrospective study (2009-2010)

Femke Mortier (UGent) , Sylvie Daminet (UGent) , Sophie Vandenabeele (UGent) and Isabel Van de Maele (UGent)
Author
Organization
Abstract
This study reviews the medical records of 56 dogs diagnosed with lymphoma based on the cytological and/or histological results between January 1, 2009 and December 31, 2010. Most of the dogs were middle-aged to old, and were diagnosed with multicentric lymphoma (ML) (n=36). The majority of the dogs were presented in stages III to V (n=55) and substage b (n=43). A complete blood count and serum biochemistry, urinalysis, serum protein electrophoresis, thoracic radiographs and/or abdominal ultrasound were performed. The results correlated with previously described results in the literature. Therapy was initiated in 80% of the dogs (n=45). After diagnosis, the median survival time of 62% of these dogs (n=28) treated with only prednisolone was 32 days (range 3 - 224 days). For 24% of the dogs (n=11) treated with chemotherapy, the median survival time was 119 days (range 11 - 273 days). Surgical resection of the macroscopic tumor was performed in the remaining six dogs (13%). Three of these dogs received subsequent prednisolone therapy. The median survival time of these six dogs was 47 days (range 0 - 669 days). The dogs that received chemotherapy had significantly longer survival times than those treated with only prednisolone, although negative prognostic factors were present in all of the cases treated with chemotherapy.
Keywords
MALIGNANT-LYMPHOMA, CHEMOTHERAPY PROTOCOL, DOGS QUALITY, B-CELL, THERAPY, CCNU, ASSOCIATION, PREDICTORS, MULTICENTRIC LYMPHOMA, EPITHELIOTROPIC LYMPHOMA

Downloads

  • DI09 Canine lymphoma a retrospective study.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 103.80 KB

Citation

Please use this url to cite or link to this publication:

MLA
Mortier, Femke et al. “Canine Lymphoma: a Retrospective Study (2009-2010).” VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT 81.6 (2012): 341–351. Print.
APA
Mortier, Femke, Daminet, S., Vandenabeele, S., & Van de Maele, I. (2012). Canine lymphoma: a retrospective study (2009-2010). VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 81(6), 341–351.
Chicago author-date
Mortier, Femke, Sylvie Daminet, Sophie Vandenabeele, and Isabel Van de Maele. 2012. “Canine Lymphoma: a Retrospective Study (2009-2010).” Vlaams Diergeneeskundig Tijdschrift 81 (6): 341–351.
Chicago author-date (all authors)
Mortier, Femke, Sylvie Daminet, Sophie Vandenabeele, and Isabel Van de Maele. 2012. “Canine Lymphoma: a Retrospective Study (2009-2010).” Vlaams Diergeneeskundig Tijdschrift 81 (6): 341–351.
Vancouver
1.
Mortier F, Daminet S, Vandenabeele S, Van de Maele I. Canine lymphoma: a retrospective study (2009-2010). VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT. 2012;81(6):341–51.
IEEE
[1]
F. Mortier, S. Daminet, S. Vandenabeele, and I. Van de Maele, “Canine lymphoma: a retrospective study (2009-2010),” VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, vol. 81, no. 6, pp. 341–351, 2012.
@article{3222298,
  abstract     = {{This study reviews the medical records of 56 dogs diagnosed with lymphoma based on the cytological and/or histological results between January 1, 2009 and December 31, 2010. Most of the dogs were middle-aged to old, and were diagnosed with multicentric lymphoma (ML) (n=36). The majority of the dogs were presented in stages III to V (n=55) and substage b (n=43). A complete blood count and serum biochemistry, urinalysis, serum protein electrophoresis, thoracic radiographs and/or abdominal ultrasound were performed. The results correlated with previously described results in the literature. Therapy was initiated in 80% of the dogs (n=45). After diagnosis, the median survival time of 62% of these dogs (n=28) treated with only prednisolone was 32 days (range 3 - 224 days). For 24% of the dogs (n=11) treated with chemotherapy, the median survival time was 119 days (range 11 - 273 days). Surgical resection of the macroscopic tumor was performed in the remaining six dogs (13%). Three of these dogs received subsequent prednisolone therapy. The median survival time of these six dogs was 47 days (range 0 - 669 days). The dogs that received chemotherapy had significantly longer survival times than those treated with only prednisolone, although negative prognostic factors were present in all of the cases treated with chemotherapy.}},
  author       = {{Mortier, Femke and Daminet, Sylvie and Vandenabeele, Sophie and Van de Maele, Isabel}},
  issn         = {{0303-9021}},
  journal      = {{VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT}},
  keywords     = {{MALIGNANT-LYMPHOMA,CHEMOTHERAPY PROTOCOL,DOGS QUALITY,B-CELL,THERAPY,CCNU,ASSOCIATION,PREDICTORS,MULTICENTRIC LYMPHOMA,EPITHELIOTROPIC LYMPHOMA}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{341--351}},
  title        = {{Canine lymphoma: a retrospective study (2009-2010)}},
  url          = {{http://vdt.ugent.be/code/showupload.php?id=760}},
  volume       = {{81}},
  year         = {{2012}},
}

Web of Science
Times cited: